Aller au contenu

Publications scientifiques

  • article Nabid A, Carrier N, Vigneault É and Martin AG, Nguyen TV, Bahary JP, Vavassis P, Bahoric B, Brassard MA, Archambault R, Vincent F, Bettahar R, Duclos M, Wilke D, Souhami L

    Impact of Persistent Hypogonadism on Overall Survival After Androgen Deprivation Therapy in Localized Prostate Cancer Patients: Long-Term Prospective Data

    Int J Radiat Oncol Biol Phys 2025.

    DOI PUBMED
  • article Nabid A, Carrier N, Martin AG, Bahary JP, Vavassis P, Vass S, Bahoric B, Archambault R, Vincent F, Bettahar R, Souhami L

    Quality of life and testosterone recovery after androgen deprivation therapy in high-risk prostate cancer patients: long-term data from a phase III trial

    Qual Life Res 34 (3), 2025.

    DOI PUBMED
  • article Niazi T, Nabid A, Malagon T, Tisseverasinghe S, Bettahar R, Dahmane R, Martin AG, Jolicoeur M, Yassa M, Barkati M, Igidbashian L, Bahoric B, Archambault R, Villeneuve H, Mohiuddin M

    Hypofractionated Dose Escalation Radiotherapy for High-Risk Prostate Cancer: the survival analysis of the Prostate Cancer Study-5 (PCS-5), a GROUQ-led phase III trial

    Eur Urol 87 (3), 2025.

    DOI PUBMED
  • article Lavallee MC, Cantin A, Aubin S, Lefebvre M, Marrier AS, Bouchard I, Fiset C, Villeneuve-Gauthier A, Foster W, Martin AG, Carignan D, Beaulieu L, Vigneault E

    US-guided EM tracked system for HDR brachytherapy: A first in-men randomized study for whole prostate treatment

    Brachytherapy 23 (1), 2024.

    DOI PUBMED
  • article Spyrou A, Martin AG, Hannoun-Lévi JM, Stewart A

    Measuring patient reported outcomes in brachytherapy: Why we should do it and more importantly how

    Clin Transl Radiat Oncol 49 2024.

    DOI PUBMED
  • article Nabid A, Carrier N, Vigneault E, Martin AG, Bahary JP, Van Nguyen T, Vavassis P, Vass S, Brassard MA, Bahoric B, Archambault R, Vincent F, Bettahar R, Duclos M, Wilke D, Souhami L

    Testosterone recovery after androgen deprivation therapy in localised prostate cancer: Long-term data from two randomised trials

    Radiother Oncol 195 2024.

    DOI PUBMED
  • article Niazi T, Nabid A, Malagon T, Bettahar R, Vincent L, Martin AG, Jolicoeur M, Yassa M, Barkati M, Igidbashian L, Bahoric B, Archambault R, Villeneuve H, Tsui JMG, Mohiuddin M

    Hypofractionated, Dose Escalation Radiation Therapy for High-Risk Prostate Cancer: The Safety Analysis of the Prostate Cancer Study-5, a Groupe de Radio-Oncologie Génito-Urinair…

    Int J Radiat Oncol Biol Phys 118 (1), 2024.

    DOI PUBMED
  • article Brière R, Martin AG, Letarte F, Fournier FR, Bouchard P, Drolet S

    Surgical management of rectal cancer with synchronous treatment of prostate cancer

    Langenbecks Arch Surg 409 (1), 2024.

    DOI PUBMED
  • article Carignan D, Morales B, Després P, Foster W, Martin AG, Vigneault E

    Differential outcomes of re-stratified high-risk prostate cancer patients treated with external beam radiation therapy plus high-dose-rate brachytherapy boost

    J Contemp Brachytherapy 16 (2), 2024.

    DOI PUBMED
  • article Ouellet S, Lemaréchal Y, Berumen-Murillo F, Lavallée MC, Vigneault É and Martin AG, Foster W, Thomson RM, Després P, Beaulieu L

    A Monte Carlo dose recalculation pipeline for durable datasets: an I-125 LDR prostate brachytherapy use case

    Phys Med Biol 68 (23), 2023.

    DOI PUBMED
  • article Lavoie-Gagnon H, Martin AG, Poulin E, Archambault L, Pilote L, Foster W, Vigneault E, Carignan D, Lacroix F

    Advantages of TRUS-based delineation for high-dose-rate prostate brachytherapy planning

    J Contemp Brachytherapy 14 (1), 2022.

    DOI PUBMED
  • article Bélanger C, Poulin É and Aubin S, Vigneault É and Martin AG, Foster W, Beaulieu L

    Inter-observer evaluation of a GPU-based multicriteria optimization algorithm combined with plan navigation tools for HDR brachytherapy

    Brachytherapy 21 (4), 2022.

    DOI PUBMED